Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure drug treatment
Patrick Rossignol, Adrian F. Hernandez, Scott D. Solomon, et al.
The Lancet (2019) Vol. 393, Iss. 10175, pp. 1034-1044
Open Access | Times Cited: 296

Showing 1-25 of 296 citing articles:

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett, et al.
Circulation (2019) Vol. 141, Iss. 5, pp. 352-361
Open Access | Times Cited: 461
Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Kevin Damman, Jeffrey M. Testani, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 4, pp. 584-603
Open Access | Times Cited: 321
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jörg Täubel, Wilfried Hauke, Steffen Rump, et al.
European Heart Journal (2020) Vol. 42, Iss. 2, pp. 178-188
Open Access | Times Cited: 284
Advances in tissue engineering of nanocellulose-based scaffolds: A review
Huize Luo, Ruitao Cha, Juanjuan Li, et al.
Carbohydrate Polymers (2019) Vol. 224, pp. 115144-115144
Closed Access | Times Cited: 194
Nanocellulose‐Based Functional Materials: From Chiral Photonics to Soft Actuator and Energy Storage
Pengfei Lv, Xiaomin Lu, Ling Wang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 45
Closed Access | Times Cited: 194
Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study
D. S. Polyakov, И. В. Фомин, Yu. N. Belenkov, et al.
Kardiologiia (2021) Vol. 61, Iss. 4, pp. 4-14
Open Access | Times Cited: 164
Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones
Anissa Viveiros, Jaslyn Rasmuson, Jennie Vu, et al.
AJP Heart and Circulatory Physiology (2020) Vol. 320, Iss. 1, pp. H296-H304
Open Access | Times Cited: 158
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure
David M. Shavelle, Akshay S. Desai, William T. Abraham, et al.
Circulation Heart Failure (2020) Vol. 13, Iss. 8
Open Access | Times Cited: 155
The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
Kazuaki Maruyama, Kyoko Imanaka‐Yoshida
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2617-2617
Open Access | Times Cited: 119
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 101
Recent Advances in Cellulose-Based Hydrogels for Tissue Engineering Applications
Chao Chen, Yuewei Xi, Yunxuan Weng
Polymers (2022) Vol. 14, Iss. 16, pp. 3335-3335
Open Access | Times Cited: 93
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology
Julio Núñez, Rafael de la Espriella, Patrick Rossignol, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1751-1766
Open Access | Times Cited: 93
A Review of Properties of Nanocellulose, Its Synthesis, and Potential in Biomedical Applications
Aayushi Randhawa, Sayan Deb Dutta, Keya Ganguly, et al.
Applied Sciences (2022) Vol. 12, Iss. 14, pp. 7090-7090
Open Access | Times Cited: 75
Regeneration of infarcted hearts by myocardial infarction-responsive injectable hydrogels with combined anti-apoptosis, anti-inflammatory and pro-angiogenesis properties
Cheng Hu, Wenqi Liu, Linyu Long, et al.
Biomaterials (2022) Vol. 290, pp. 121849-121849
Closed Access | Times Cited: 75
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan
Scott D. Solomon, Pardeep S. Jhund, Brian Claggett, et al.
JACC Heart Failure (2020) Vol. 8, Iss. 10, pp. 811-818
Open Access | Times Cited: 122
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry
Patrick Rossignol, Mitja Lainščak, María G. Crespo‐Leiro, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1378-1389
Open Access | Times Cited: 111
Heart Failure Risk Associated With Rheumatoid Arthritis–Related Chronic Inflammation
Michael Ahlers, Brandon D. Lowery, Eric Farber‐Eger, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 10
Open Access | Times Cited: 82
The Renin-Angiotensin System in the Central Nervous System and Its Role in Blood Pressure Regulation
Pablo Nakagawa, Javier A. Gomez, Justin L. Grobe, et al.
Current Hypertension Reports (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Microengineered platforms for characterizing the contractile function of in vitro cardiac models
Wenkun Dou, Manpreet Malhi, Qili Zhao, et al.
Microsystems & Nanoengineering (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Practical outpatient management of worsening chronic heart failure
Nicolas Girerd, Nathan Mewton, Jean‐Michel Tartière, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 5, pp. 750-761
Open Access | Times Cited: 43
Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
Nicolas Girerd, Jean‐Jacques Von Hunolstein, Pierpaolo Pellicori, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 4, pp. 2063-2069
Open Access | Times Cited: 40
Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction
Arjun Pandey, Deepak L. Bhatt, Avinash Pandey, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3640-3651
Closed Access | Times Cited: 37
Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts
Nicolas Girerd, Christophe Leclercq, Olivier Hanon, et al.
Revista Española de Cardiología (English Edition) (2023) Vol. 76, Iss. 10, pp. 813-820
Open Access | Times Cited: 31
Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies
Mohammad Saeed Kahrizi, Elnaz Mousavi, Armin Khosravi, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Risk Factors Associated with Cardiovascular Disorders
Muhammad Mudasser Hussain, Uzma Rafi, Adnan Imran, et al.
Pakistan BioMedical Journal (2024), pp. 03-10
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top